Leef Brands (LEEEF) EBT (2025 - 2026)

Leef Brands' (LEEEF) quarterly EBT came in at $548327.0 in Q1 2026, down 44.44% year-on-year from $986889.0 in Q1 2025, and down 44.44% quarter-over-quarter from $986889.0 in Q1 2025.

Leef Brands (LEEEF) EBT (2025 - 2026) Analysis & Trends

Leef Brands has disclosed EBT across 2 years of filings, most recently posting $548327.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 437.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 758.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 318.30 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 17.47 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 246.80 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 87.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -61.93 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 156.41 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -101.55 Mn
10 Leef Brands - - 4.62 Mn 548,327.00

Historic Data

Download Data
DateValue
Mar 31, 2026 548,327.00
Mar 31, 2025 986,889.00